🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Treatment Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of members share comparison photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several professionals said the demand for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the service has removed violative material and prohibited associated hashtags and query recommendations. The organization stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, populated with photos of weight loss, glowing testimonials and detailed instructions for preparing or administering at residence.

Within moments of joining one community, a seller shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.

Item Information and Costs

Inside these groups, messages show black plastic packages with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram said it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is valid, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has already encountered patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to potentially significant health risks”.